1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. HBM Holdings Limited
  6. Summary
    2142   KYG4403H1002

HBM HOLDINGS LIMITED

(2142)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Hong Kong Stock Exchange
05/20/2022 05/23/2022 05/24/2022 05/25/2022 05/26/2022 Date
3.93(c) 3.88(c) 3.67(c) 3.69(c) 3.63 Last
3 264 000 2 999 000 2 005 000 1 675 000 819 000 Volume
+5.36% -1.27% -5.41% +0.54% -1.63% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 56,2 M - -
Net income 2022 -109 M - -
Net cash position 2022 173 M - -
P/E ratio 2022 -3,22x
Yield 2022 -
Sales 2023 96,0 M - -
Net income 2023 -118 M - -
Net cash position 2023 48,5 M - -
P/E ratio 2023 -3,60x
Yield 2023 -
Capitalization 342 M 342 M -
EV / Sales 2022 3,01x
EV / Sales 2023 3,05x
Nbr of Employees 396
Free-Float 72,4%
More Financials
Company
HBM Holdings Ltd is an investment holding company mainly engaged in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. The Company’s products include batoclimab, mainly used for immune thrombocytopenia (ITP), graves’ ophthalmopathy (GO), myasthenia gravis (MG), neuromyelitis optica spectrum disorder (NMOSD); and tanfanercept, mainly used for dry eye... 
Sector
Pharmaceuticals
Calendar
06/03Presentation
More about the company
Ratings of HBM Holdings Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about HBM HOLDINGS LIMITED
05/25UPDATE ON OVERNIGHT STOCKS TO WATCH : HudBay Minerals Up 1%; Gran Tierra Energy Up 3%. Als..
MT
05/25Samsung Electronics, Red Hat to Collaborate Next-Generation Memory Software
MT
05/25MT NEWSWIRES CANADA OVERNIGHT STOCKS : HudBay Minerals; Gran Tierra Energy; Teck Resources
MT
05/25Hudbay Minerals Receives Favorable US Court Ruling on Copper World Project
MT
05/11RBC Capital Markets Cuts Hudbay's Price Target
MT
05/10RBC Capital Markets Says Hudbay's Q1 Results Miss Estimates Due To Lower Sales Volumes
MT
05/10Scotiabank Notes Hudbay's Q1 Results Miss, Reaffirmed Guidance
MT
05/10Hbm Holdings Limited Announces Data Release Forecast of Hbm4003 At ASCO 2022
CI
05/10HudBay Minerals Swings to Adjusted Earnings in Q1, Revenue Rises
MT
05/06HBM Healthcare Investments Sinks To FY22 Loss On Negative Result From Investment Activi..
MT
05/06Harbour BioMed Appoints Dr. Alexander A. Zukiwski to its Scientific Advisory Board
CI
05/05Harbour BioMed Appoints Dr. Alexander A. Zukiwski to its Scientific Advisory Board
PR
05/05HBM Holdings Limited Announces Board Changes
CI
05/02HBM Healthcare Investments Sees 3% Drop in April NAV
MT
04/14HBM Appoints New Chief Medical Officer
MT
More news
News in other languages on HBM HOLDINGS LIMITED
05/25MISE À JOUR SUR LES ACTIONS À SURVEI : HudBay Minerals en hausse de 1% ; Gran Tierra Energ..
05/25Samsung Electronics et Red Hat vont collaborer sur un logiciel de mémoire de nouvelle g..
05/25Hudbay Minerals reçoit un jugement favorable du tribunal américain sur le projet Copper..
05/11AKTIEN SCHWEIZ SCHLUSS : SMI nach US-Teuerung höher - Roche bremst Anstieg aus
05/11RBC Capital Markets réduit l'objectif de cours de Hudbay
More news
Chart HBM HOLDINGS LIMITED
Duration : Period :
HBM Holdings Limited Technical Analysis Chart | 2142 | KYG4403H1002 | MarketScreener
Technical analysis trends HBM HOLDINGS LIMITED
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 0,47 $
Average target price 1,02 $
Spread / Average Target 117%
EPS Revisions
Managers and Directors
Jing Song Wang Chairman & Chief Executive Officer
Yingying Chen Chief Financial Officer
Li Le Liu SVP, Head-Technology Platform & Suzhou Operations
Humphrey A. R. Gardner Chief Medical Officer
Robert Irwin Kamen Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
HBM HOLDINGS LIMITED-52.39%342
MERCK KGAA-22.27%81 684
KYOWA KIRIN CO. LTD.-12.79%11 611
SK BIOPHARMACEUTICALS CO., LTD.-10.08%5 298
YUHAN CORPORATION-3.86%3 181
BETTA PHARMACEUTICALS CO., LTD.-43.63%2 785